Fructose-1,6-bisphosphatase (D-fructose-1,6-bisphosphate 1-phosphohydrolase; EC 3.1.3.11) has been found in rat brain and identified unequivocally. The enzyme has been purified to 95% homogeneity by standard procedures, including adsorption to a phosphocellulose column followed by elution with substrate. 
in brain slices. Recently, in connection with a study of the inhibition of glycolysis by phospholipid in brain, we have demonstrated the conversion of ['4C ]fructose 1,6-bisphosphate (Fru-P2) into [14C]fructose 6-phosphate (5), presumptive evidence for the existence of a phosphatase. In this paper we describe the isolation, purification, and characterization of a specific Fru-P2ase from mammalian brain (6) .
MATERIALS AND METHODS

Materials
Sodium salts of Fru-P2, glucose 6-phosphate, fructose 6-phosphate, sedoheptulose 1,7-bisphosphate, glucose 1-phosphate, fructose 1-phosphate, f-glycerophosphate, 5 '-AMP, and the tetracyclohexylammonium salt of glucose 1,6-bisphosphate were purchased from the Sigma Chemical Co. Tetracyclohexylammonium glycerol 1,3-bisphosphate was from Calbiochem. All other reagents were the best grade available.
Phosphocellulose P11, obtained from Whatman, Inc., was washed according to the procedure of Han et al. (7) and finally
The costs of publication of this article were defrayed in part by the payment of page charges from funds made available to support the research which is the subject of the article. This article must therefore be hereby marked "advertisement" in accordance with 18 (9) . Isolation and purification of Fru-P2ase from brain, by a procedure described by Traniello et al. (10) for purification of rabbit liver enzyme with minor modification, is outlined as follows. All operations were carried out at 0-4°.
Step I. Low-speed supernatant: Brain (12 g) from 12 male Osborne-Mendel rats (weighing 150-200 g) was homogenized with three volumes of 0.15 M KCI containing 0.01 M NaHCO3 for 1-2 min and the homogenate was centrifuged at 10,000 X g for 20 min. The supernatant obtained (termed low-speed supernatant) was passed through a thin pad of glass wool to trap lipid particles.
Step II. Heat treatment: The low-speed supernatant was heated to 600 in a water bath maintained at 90-950. After 3 min at 600 the enzyme solution was rapidly chilled and centrifuged in a 50 Ti rotor at 40,000 rpm for 60 min in an L265B ultracentrifuge.
Step III. Acid fractionation: The supernatant was adjusted to pH 4.5 Fru-P2ase activity. Fractions containing highest activity were pooled, adjusted to pH 7.6 by Tris, and incubated at 370 for 40 min for hydrolysis of the bound Fru-P2, a procedure similar to that described by Taketa et al. (11) . The solution was then placed in a dialysis sac and covered with dry Sephadex G-200 to reduce volume. The concentrated enzyme (about 2 ml) was dialyzed against 1 liter of 10 mM Tris-HCI buffer, pH 7.0, and stored frozen at -200. Standard disc gel electrophoresis was carried out in 7% acrylamide gels (12) ; and disc gel electrophoresis was in 0.1% sodium dodecyl sulfate (NaDodSO4), according to Weber and Osborn (13) , in 5% acrylamide gels. For NaDodSO4 gel electrophoresis, protein samples were heated in a solution of 10 mM phosphate buffer, pH 7.0, containing 1% NaDodSO4/0.5 M urea/1% mercaptoethanol in a boiling-water bath for 30 min before they were placed on the gel. Gels were stained overnight in 0.05% Coomassie brilliant blue/45% methanol/9% acetic acid (vol/vol) and destained by soaking in repeated changes of 7.5% acetic acid/5% methanol (vol/vol). Gels were stored in 7% formalin.
For preparation of antiserum against brain Fru-P2ase, 3 mg of phosphocellulose-purified enzyme, emulsified with an equal volume of Freund's complete adjuvant (Difco) was injected into sheep, followed 2 weeks later by a similar injection. The animal was bled 5 weeks after the first injection and the serum was separated from the clot by centrifugation at 10,000 X g for 30 min. The undiluted serum was adjusted to 40% saturation with ammonium sulfate. The precipitate formed was dissolved in the minimum volume of 0.9% buffered saline, pH 7.6, and dialyzed exhaustively against the same solution. Protein was estimated by the procedure of Lowry et al. (14) .
Crude extracts of liver and kidney containing 0.5 unit of Fru-P2ase/ml were prepared according to Tejwani et al. (15) . (One unit of enzyme is the amount causing hydrolysis of 1 nmol of Fru-P2 per hr.) Purified rat liver Fru-P2ase and its antiserum produced in rabbits were gifts from B. L. Horecker, Roche Institute of Molecular Biology. (Fig. 1D) , the subunit molecular weight of the brain Fru-P2ase was estimated at about 40,000. The enzyme activity was found to correspond to the major protein band when slices were assayed after electrophoresis in a, standard 7% acrylamide gel without NaDodSO4. Fig. 1 A and B shows the course of purification prior to phosphocellulose column chromatography.
RESULTS
Purification
Effect of pH, divalent cation, 5.-AMP, and phospholipid on catalytic activity
In the absence of added divalent cation, brain Fru-P2ase has been found to be optimally active in a broad range between pH 7.6 and 9.5 (Fig. 2) kidney fractions only but not with the purified brain enzyme (Fig. 3A) . The precipitin bands consisted of a major outer band and a minor inner band, although only the major band was observed in separate experiments using purified liver enzyme (not shown). Fig. 3B shows the results of similar experiments using antiserum produced in sheep against the purified brain enzyme. Only the brain Fru-P2ase crossreacts with the antiserum. The fainter precipitin lines with the liver and kidney enzymes suggest the presence of other antibodies in the antiserum against brain Fru-P2ase.
Preliminary experiments suggested that the brain Fru-P2ase forms a precipitate when incubated with its antiserum and, moreover, that the enzyme-antibody complex is catalytically active. The results of the Ouchterlony double-diffusion experiments described above were thus confirmed by enzyme precipitation experiments, as illustrated in Fig. 4 (1977) calculations from the data in Table 1 reveal that Fru-Pja*e comprises about 0.32% of the total protein in the brain lowspeed supernatant (about 1.4 mg in 450 mg of low-speed supernatant protein). This value is similar to the 0.36% reported for the chicken liver enzyme (17) . The purified brain enzyme catalyzes the hydrolysis of 0.13 ,mol of Fru-P2/min per mg of protein at pH 7.6 compared with a value of 29 ,gmol reported for the liver enzyme (15) . The low gluconeogenic activity of brain compared with liver (16) may in part be a reflection of this lower specific activity of Fru-P2ase rather than any dearth of enzyme.
Compared to the liver enzyme, the brain enzyme has similar subunit molecular weight, higher Km for Fru-P2, and identical substrate specificity; bovine liver Fru-P2ase differs in exhibiting activity towards fl-glycerophosphate (18) . With respect to the lack of inhibition by 5'-AMP, the brain Fru-P2ase is different from liver, kidney, and mammalian muscle enzymes but similar to the Fru-P2ase of flight muscle of bumblebee (19) . A further striking difference between Fru-P2ase from brain and other tissues is the absence of a metal requirement for activity. No divalent cation is associated with the enzyme, as indicated by the failure of EDTA to inhibit, nor did the addition of Mg2+, Ca2+, Mn2+, or Co2+ stimulate.
An important property of the brain enzyme is its immunological difference from the liver enzyme, because the former fails to crossreact with the antibody to purified rat liver enzyme (Fig. 3A) . To what extent structure contributes to the immunological differences between the two enzymes must await further investigation. No immunological comparison of brain and muscle enzymes has been made.
The search for Fru-P2ase in brain was prompted by an earlier study which showed that the addition of phospholipid to brain supernatant caused the accumulation of glucose 6-phosphate (5). The effect was localized at the level of the fructose phosphates of the glycolytic cycle. Since stimulation of Fru-P2ase could account for the accumulation of glucose 6-phosphate and since, moreover, we had observed in the same study the conversion of [14C]Fru-P2 into [14C]fructose 6-phosphate, we undertook the search for this enzyme. Although we have demonstrated unequivocally that brain contains Fru-P2ase, further study has shown that it is not the enzyme to which the inhibitory effect of phospholipid on glycolysis can be attributed. This was shown both by the inertness of the purified enzyme toward phosphatidylcholine and the lack of any increase in labeled inorganic phosphate from [1-32P] Fru-P2 under conditions in which phosphatidylcholine causes glucose 6-phosphate to accumulate. The responsible enzyme then must be phosphofructokinase, which in other tissues is in fact inhibited by phospholipid (20) . Whether the brain phosphofructokinase (21) is also inhibited by phospholipid awaits further study.
Our-unequivocal demonstration of Fru-P2ase in brain provides a direct pathway from Fru-P2 to fructose 6-phosphate and, together with phosphofructokinase, the potential for a hitherto unknown fructose phosphate "futile cycle" in brain, a possible control point in the distribution of glucose 6-phosphate between glycolysis and other pathways of utilization.
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